Principal Financial Group
BIVV

Principal Financial Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Principal Financial Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-461,103
Closed -$24.9M – 2272
2017
Q4 		$24.9M Sell
461,103
-92,086
-17% -$5.04M 0.02% 683
2017
Q3 		$31.6M Sell
553,189
-39,194
-7% -$2.3M 0.03% 555
2017
Q2 		$35.6M Buy
592,383
+156,783
+36% +$8.93M 0.04% 509
2017
Q1 		$23.7M Buy
+435,600
New +$21.5M 0.03% 622

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Principal Financial Group's BIVV Position: Q1 2018 in Review

Principal Financial Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 461,103 shares — an estimated $24.9M sold.

Principal Financial Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $35.6M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Principal Financial Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Principal Financial Group sold 461,103 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $24.9M.
  • Principal Financial Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Principal Financial Group's Bioverativ Inc. Common Stock position peaked at $35.6M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Principal Financial Group's 13F filing for Q1 2018, filed 14 May 2018.